Provectus Biopharmaceuticals, Inc.
PVCT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$4,762 | -$3,102 | -$3,555 | -$5,540 |
| Dep. & Amort. | $7 | $9 | $11 | $13 |
| Deferred Tax | $0 | $0 | $0 | -$63 |
| Stock-Based Comp. | $1,281 | $3 | $3 | $24 |
| Change in WC | $143 | $473 | $446 | $4,472 |
| Other Non-Cash | $47 | $45 | $53 | $81 |
| Operating Cash Flow | -$3,284 | -$2,572 | -$3,041 | -$1,013 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,448 | $2,192 | $0 | $2,912 |
| Stock Issued | $300 | $0 | $0 | $962 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1,368 | $1,262 |
| Financing Cash Flow | $2,748 | $2,192 | $1,368 | $4,024 |
| Forex Effect | -$1 | -$24 | -$2 | -$1 |
| Net Chg. in Cash | -$537 | -$405 | -$1,675 | $3,010 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,027 | $1,432 | $3,107 | $97 |
| End Cash | $490 | $1,027 | $1,432 | $3,107 |
| Free Cash Flow | -$3,284 | -$2,572 | -$3,041 | -$1,013 |